Nifty
:
11937.65
Sensex
:
40707.31
40.85 (0.34%)
162.94 (0.40%)
Nifty
Sensex
:
:
11937.65
40707.31
40.85 (0.34%)
162.94 (0.40%)

Syncom Formulations (India) Ltd.

Pharmaceuticals & Drugs

Rating :
67/99

BSE: 524470 | NSE: Not Listed

NSE BSE
1.39
21-Oct-2020
  • Open
  • High
  • Low
  • Previous Close
  •  1.39
  •  1.40
  •  1.37
  •  1.39
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  381
  •  7.11
  •  2.46
  •  0.39

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 108.51
  • 7.62
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 109.40
  • N/A
  • 0.73

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.48%
  • 1.89%
  • 54.52%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.14
  • 1.50
  • 0.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.53
  • -8.25
  • -6.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.66
  • 2.59
  • 1.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.87
  • 10.49
  • 8.10

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.71
  • 0.71
  • 0.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.54
  • 6.82
  • 5.24

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
-
184.82
183.90
173.39
151.29
114.95
Net Sales Growth
-
0.50%
6.06%
14.61%
31.61%
 
Cost Of Goods Sold
-
102.80
106.54
116.00
101.72
77.54
Gross Profit
-
82.03
77.36
57.40
49.57
37.41
GP Margin
-
44.38%
42.07%
33.10%
32.76%
32.54%
Total Expenditure
-
168.27
167.23
155.18
135.02
104.30
Power & Fuel Cost
-
3.01
2.69
2.76
2.40
1.93
% Of Sales
-
1.63%
1.46%
1.59%
1.59%
1.68%
Employee Cost
-
14.45
13.48
13.38
11.35
10.06
% Of Sales
-
7.82%
7.33%
7.72%
7.50%
8.75%
Manufacturing Exp.
-
26.74
27.01
1.55
1.03
0.64
% Of Sales
-
14.47%
14.69%
0.89%
0.68%
0.56%
General & Admin Exp.
-
8.86
8.36
7.54
6.60
6.58
% Of Sales
-
4.79%
4.55%
4.35%
4.36%
5.72%
Selling & Distn. Exp.
-
12.09
8.90
13.72
11.84
7.47
% Of Sales
-
6.54%
4.84%
7.91%
7.83%
6.50%
Miscellaneous Exp.
-
0.31
0.26
0.23
0.08
0.08
% Of Sales
-
0.17%
0.14%
0.13%
0.05%
0.07%
EBITDA
-
16.55
16.67
18.21
16.27
10.65
EBITDA Margin
-
8.95%
9.06%
10.50%
10.75%
9.26%
Other Income
-
2.79
2.67
1.98
1.12
1.15
Interest
-
0.33
0.14
0.29
0.47
0.52
Depreciation
-
3.12
3.00
3.40
2.99
2.83
PBT
-
15.89
16.20
16.49
13.93
8.45
Tax
-
5.34
5.75
5.88
4.61
2.79
Tax Rate
-
33.63%
35.71%
37.62%
33.09%
33.02%
PAT
-
10.53
10.36
9.76
9.32
5.66
PAT before Minority Interest
-
10.53
10.36
9.76
9.32
5.66
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
5.70%
5.63%
5.63%
6.16%
4.92%
PAT Growth
-
1.64%
6.15%
4.72%
64.66%
 
EPS
-
0.13
0.13
0.13
0.12
0.07

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
117.35
108.70
100.22
95.20
87.71
Share Capital
78.07
78.07
78.07
78.07
22.30
Total Reserves
39.29
30.63
22.16
17.13
65.40
Non-Current Liabilities
7.73
6.27
5.62
6.81
8.28
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
Current Liabilities
58.84
65.69
36.66
41.62
28.50
Trade Payables
32.27
46.94
19.92
29.35
19.43
Other Current Liabilities
5.84
3.67
1.63
0.86
1.72
Short Term Borrowings
12.45
5.62
6.08
3.30
2.05
Short Term Provisions
8.27
9.46
9.04
8.11
5.30
Total Liabilities
183.92
180.66
142.50
143.63
124.49
Net Block
55.04
45.85
45.78
50.26
50.47
Gross Block
91.98
82.41
80.43
77.18
74.40
Accumulated Depreciation
36.94
36.56
34.65
26.93
23.93
Non Current Assets
97.38
88.99
58.91
65.54
62.50
Capital Work in Progress
0.25
4.72
0.00
0.00
0.00
Non Current Investment
35.91
23.37
6.38
9.31
6.74
Long Term Loans & Adv.
6.18
15.05
6.75
5.97
5.29
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
Current Assets
86.54
91.66
83.59
78.09
61.99
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
10.01
15.47
10.94
9.90
6.07
Sundry Debtors
45.99
46.00
31.16
29.42
28.94
Cash & Bank
6.52
5.69
6.77
5.28
3.76
Other Current Assets
24.02
8.41
9.25
5.87
23.22
Short Term Loans & Adv.
13.52
16.10
25.47
27.63
17.28
Net Current Assets
27.70
25.98
46.93
36.47
33.49
Total Assets
183.92
180.65
142.50
143.63
124.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
13.84
24.07
0.08
6.73
5.78
PBT
15.88
16.10
16.49
13.93
8.45
Adjustment
0.71
1.14
2.59
2.36
2.24
Changes in Working Capital
1.29
12.29
-12.51
-5.54
-2.58
Cash after chg. in Working capital
17.88
29.53
6.58
10.76
8.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.03
-5.35
-5.64
-4.02
-2.34
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-0.01
-0.10
-0.86
0.00
0.00
Cash From Investing Activity
-17.68
-22.74
0.74
-4.28
-0.32
Net Fixed Assets
-5.10
-6.70
-3.25
-2.78
Net Investments
-7.49
-16.99
2.83
-2.57
Others
-5.09
0.95
1.16
1.07
Cash from Financing Activity
4.67
-2.40
0.68
-0.93
-6.38
Net Cash Inflow / Outflow
0.83
-1.08
1.50
1.52
-0.92
Opening Cash & Equivalents
5.69
6.77
5.28
3.76
4.68
Closing Cash & Equivalent
6.52
5.69
6.77
5.28
3.76

Financial Ratios

Standalone /

Consolidated
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
1.50
1.39
1.28
1.22
1.12
ROA
5.78%
6.41%
6.82%
6.95%
4.54%
ROE
9.32%
9.91%
9.99%
10.19%
6.45%
ROCE
13.28%
14.72%
15.55%
15.29%
10.00%
Fixed Asset Turnover
2.12
2.28
2.20
2.00
1.55
Receivable days
90.83
75.88
63.71
70.22
91.86
Inventory Days
25.15
25.97
21.92
19.22
19.28
Payable days
91.28
73.89
59.55
67.54
70.98
Cash Conversion Cycle
24.70
27.96
26.08
21.90
40.17
Total Debt/Equity
0.11
0.05
0.06
0.03
0.02
Interest Cover
48.48
119.10
54.58
30.75
17.10

Top Investors:

iepf

Annual Reports:

FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.